Cardiovascular Systems Financials

Cardiovascular Systems Stock Summary

Cardiovascular Systems competes with Orthofix Medical, Glaukos Corp, Bruker, MaxCyte, and Sight Sciences. Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota. Cardiovascular Syst operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 725 people.

Cardiovascular Systems Key Financial Ratios

Cardiovascular Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cardiovascular Systems's current stock value. Our valuation model uses many indicators to compare Cardiovascular Systems value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cardiovascular Systems competition to find correlations between indicators driving Cardiovascular Systems's intrinsic value. More Info.Cardiovascular Systems is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cardiovascular Systems' earnings, one of the primary drivers of an investment's value.

Cardiovascular Systems Market Pulse

Along with financial statement analysis, the daily predictive indicators of Cardiovascular Systems help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cardiovascular Systems. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cardiovascular Systems based on widely used predictive technical indicators. In general, we focus on analyzing Cardiovascular Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cardiovascular Systems's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.